M.D. The division is responsible for research, education and treatment that includes, but is not limited to, clinical psychopharmacology. Integration of clinical psychopharmacology with psychosocial approaches is a major interest of investigators within the division. The division provides educational programs to undergraduate and postgraduate students as well as continuing medical education groups which provide for the optimal utilization of advances in pharmacological treatment of psychiatric patients. Divisional activities extend to many clinical facilities within the Vanderbilt system as well as other public and private programs within the Nashville area.
Specific emphasis is placed on patients with schizophrenia and related disorders.
Research within the division spans both preclinical basic research and human research that includes biological measures as well as clinical trials. The division is also engaged in clinical services research, research on the early precursors of schizophrenia and the possibility of preventive intervention.